Frank Zavrl

Director/Board Member at CERVOMED INC.

58 year

Finance

Consumer Services

Health Technology

Profile

Frank E.
Zavrl is a Non-Executive Director at EIP Pharma, Inc. and a Director at CervoMed, Inc. He was an Independent Director at Puma Biotechnology, Inc. from 2015 to 2020.
He worked as an Equity Analyst at Adage Capital Management LP and as an Analyst at Zurich Scudder Investments, Inc. He was also a Portfolio Manager at Merlin Biomed Group LLC from 1999 to 2002.
Zavrl received his undergraduate degree from the University of California, Berkeley and his MBA from the Tuck School of Business at Dartmouth.

Frank Zavrl active positions

Companies	Position	Start
CERVOMED INC.	Director/Board Member	2023-08-15
EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	Director/Board Member	-

All active positions of Frank Zavrl

Former positions of Frank Zavrl

Companies	Position	End
PUMA BIOTECHNOLOGY, INC.	Director/Board Member	2020-07-05
Merlin Biomed Group LLC Merlin Biomed Group LLC Investment ManagersFinance Merlin Biomed Group LLC is a venture capital/private equity firm located in New York City	Corporate Officer/Principal	2001-12-31
Zurich Scudder Investments, Inc.	Corporate Officer/Principal	1998-12-31
Adage Capital Management LP Adage Capital Management LP Investment ManagersFinance Adage Capital Management LP (Adage) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Phil Gross and Robert Atchinson in 2001 and is owned by Adage Capital Partners GP LLC. Adage provides investment advisory services to its sole client, Adage Capital Partners LP (ACP), a private investment fund. The firm does not manage any separate accounts.	Analyst-Equity	-

See the detail of Frank Zavrl's experience

Training of Frank Zavrl

University of California, Berkeley	Undergraduate Degree
Tuck School of Business at Dartmouth	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Frank Zavrl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
PUMA BIOTECHNOLOGY, INC.	Health Technology
CERVOMED INC.	Commercial Services

Private companies	4
Adage Capital Management LP Adage Capital Management LP Investment ManagersFinance Adage Capital Management LP (Adage) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Phil Gross and Robert Atchinson in 2001 and is owned by Adage Capital Partners GP LLC. Adage provides investment advisory services to its sole client, Adage Capital Partners LP (ACP), a private investment fund. The firm does not manage any separate accounts.	Finance
Zurich Scudder Investments, Inc.	Finance
Merlin Biomed Group LLC Merlin Biomed Group LLC Investment ManagersFinance Merlin Biomed Group LLC is a venture capital/private equity firm located in New York City	Finance
EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	Health Technology

See company connections